For: | Tashani M, Jayasinghe S, Harboe ZB, Rashid H, Booy R. Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction. World J Clin Pediatr 2016; 5(3): 311-318 [PMID: 27610348 DOI: 10.5409/wjcp.v5.i3.311] |
---|---|
URL: | https://www.wjgnet.com/2219-2808/full/v5/i3/311.htm |
Number | Citing Articles |
1 |
Wei-Chun Chen, Yen-Pin Lin, Chao-Min Cheng, Ching-Fen Shen, Alex Ching, Ting-Chang Chang, Ching-Ju Shen. Antibodies against SARS-CoV-2 Alpha, Beta, and Gamma Variants in Pregnant Women and Their Neonates under Antenatal Vaccination with Moderna (mRNA-1273) Vaccine. Vaccines 2022; 10(9): 1415 doi: 10.3390/vaccines10091415
|
2 |
M. Tashani, M. Alfelali, O. Barasheed, A.S. Alqahtani, L. Heron, M. Wong, H. Rashid, R. Booy. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial. Vaccine 2016; 34(48): 5929 doi: 10.1016/j.vaccine.2016.10.020
|
3 |
Mohamed Tashani, Al-Mamoon Badahdah, Mohammad Alfelali, Osamah Barasheed, Amani S. Alqahtani, Leon Heron, Melanie Wong, Jennifer Louth, Harunor Rashid, Ray Borrow, Robert Booy. Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial. Vaccine 2019; 37(27): 3562 doi: 10.1016/j.vaccine.2019.05.025
|
4 |
Anand Kawade, Girish Dayma, Aditi Apte, Nilima Telang, Meenakshi Satpute, Emma Pearce, Lucy Roalfe, Rakesh Patil, Yanyun Wang, Navideh Noori, Arun Gondhali, Sanjay Juvekar, Assaf P. Oron, Sonali Sanghavi, David Goldblatt, Ron Dagan, Ashish Bavdekar. Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children. Vaccine 2023; 41(19): 3066 doi: 10.1016/j.vaccine.2023.04.008
|
5 |
Shabir A Madhi, Eleonora AML Mutsaerts, Alane Izu, Welekazi Boyce, Sutika Bhikha, Benit T Ikulinda, Lisa Jose, Anthonet Koen, Amit J Nana, Andrew Moultrie, Lucy Roalfe, Adam Hunt, David Goldblatt, Clare L Cutland, Jeffrey R Dorfman. Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial. The Lancet Infectious Diseases 2020; 20(12): 1426 doi: 10.1016/S1473-3099(20)30289-9
|
6 |
Mohamed Tashani, Leon Heron, Melanie Wong, Harunor Rashid, Robert Booy. Tetanus–diphtheria–pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): a randomized, controlled trial⋆. Journal of Travel Medicine 2017; 24(4) doi: 10.1093/jtm/tax006
|
7 |
Mohamed Tashani, Harunor Rashid, Kim Mulholland, Robert Booy. Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children. Pneumonia 2016; 8(1) doi: 10.1186/s41479-016-0016-8
|